Effects of electroacupuncture and Chinese kidney-nourishing medicine on polycystic ovary syndrome in obese patients

Journal of Traditional Chinese Medicine

Volumn 33, Issue 3, 2013, Pages 287-293

  Yu, Liqing ^a   Liao, Yanjun ^b   Wu, Huangan ^b   Zhao, Jimeng ^b   Wu, Luyi ^b   Shi, Yin ^b   Fang, Jianqiao ^c  

^a Tianshan Hospital of Traditional Chinese Medicine   (China)

^b Shanghai Institute of Acupuncture Moxibustion and Meridian   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Electroacupuncture; Insulin; Leptin; Obesity; Polycystic ovary syndrome; Reinforcing kidney

Indexed keywords

ADIPONECTIN; ANGELICA ROOT EXTRACT; FRUCTUS PSORALEAE EXTRACT; HERBA EPIMEDIUM EXTRACT; HERBACEOUS AGENT; INSULIN; LEPTIN; PLASTRUM TESTUDINIS EXTRACT; POLYGONUM CUSPIDATUM EXTRACT; REHMANNIA EXTRACT; RHIZOMA ACORI GRAMINEI EXTRACT; RHIZOMA ANEMARRHENAE EXTRACT; RHIZOMA POLYGONATI EXTRACT; SEMEN PERSICAE EXTRACT; UNCLASSIFIED DRUG; VERBENAE EXTRACT;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHINESE MEDICINE; ELECTROACUPUNCTURE; FEMALE; FRUCTUS PSORALEAE; GLUCOSE METABOLISM; HERBA EPIMEDIUM; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID METABOLISM; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PLASTRUM TESTUDINIS; POLYGONUM CUSPIDATUM; RHIZOMA ACORI GRAMINEI; RHIZOMA ANEMARRHENAE; RHIZOMA POLYGONATI; SEMEN PERSICAE; VERBENACEAE; WAIST HIP RATIO;

EID: 84880498835     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(13)60166-1     Document Type: Article

References (42)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333(13): 853-861.
2. Alle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 2002; 77(6): 1095-1105.
3. Li Q H, Wu X K, Hou L H. The research progress of the correlation between obesity and polycystic ovary syndrome. Shi Jie Zhong Xi Yi Jie He Za Zhi 2008; 3(3): 177-179.
4. Shi Y, Yu L Q, Yin X J. Clinical study of acupuncture in treating obese patients with polycystic ovary syndrome. Zhong Hua Zhong Yi Yao Xue Kan 2010; 28(4): 805-807.
5. Shi Y, Feng H J, Liu H R, Zhu D. Observation on therapeutic effect of acupuncture combined with chinese herbs on polycystic ovary syndrome of kidney deficiency and phlegm stasis type. Zhong Guo Zhen Jiu 2009; 29(2): 99-102.
6. Shi Y, Xu W F, Yin X J, Zhu D. Clinical study of acupuncture combined with chinese herbs in treating polycystic ovary syndrome of kidney Yin deficiency. Shanghai Zhong Yi Yao Za Zhi 2009; 43(10): 33-35.
7. The Rotterdam ESHRE/ASRM-Sponsored PCOS Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81(1): 19-25.
8. Chen Z J, Liu J Y. Polycystic Ovary Syndrome-Basic and Clinical. Beijing: People's Medical Publishing House, 2009: 8.
9. Zhu L H. Thought and method of Traditional Chinese Medicine treatment to polycystic ovary syndrome. Neimenggu Zhong Yi Yao 2007; 26(3): 18-19.
10. Wang X C, Wang G H, Ma J L, Liu P. Combined traditional Chinese and Western Medicine treatment of 20 cases of polycystic ovary syndrome merger infertility. Xian Dai Zhong Xi Yi Jie He Za Zhi 2001; 10(20): 1941.
11. Yu J. Combined traditional Chinese and Western Medicine treatment of polycystic ovary syndrome. Zhong Guo Shi Yong Fu Ke Yu Chan Ke Za Zhi 2002; 18(11): 651-653.
12. Wang Y H. Combined traditional Chinese and Western Medicine treatment of infertility caused by polycystic ovary syndrome. Zhong Guo Dang Dai Yi Yao 2010; 17(20): 93-94.
13. Qian Y, Hu G H, Qi C. Clinical observation of nourishing kidney and activating blood herbs in treating Polycystic Ovary Syndrome. Shanghai Zhong Yi Yao Za Zhi 2011; 45(9): 48-50.
14. Liang C, Cong J, Chang H, Kuang H Y, Hou L H, Wu X K. Controlling Effect of Bushenhuatan Compound on the insulin signal conducting molecule inside ovaries in polycystic ovary syndrome model rats. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2011; 31(12): 1639-1644.
15. Ma Y K, Yang J G, Sui M, Liang K, Deng H Y, Wei W. Study the therapeutic effect of berberine on PCOS patients with insulin resistance. Zhong Guo Shi Yong Fu Ke Yu Chan Ke Za Zhi 2011; 27(9): 684-687.
16. Hu X F. Research on treatment of polycystic ovary syndrome (PCOS) infertility. Ya Tai Chuan Tong Yi Yao 2011; 7(11): 70-71.
17. Hu XL. Observation of curative effect on Metformin combined with rosiglitazone treating polycystic ovary syndrome. Zhong Guo Dang Dai Yi Yao 2010; 17(18): 66.
18. Wolf A M, Wolf D, Avila M A, et al. Up-regulation of the Anti-inflammatory adipokine adiponectin in acute liver failure in mice. J Hepatol 2006; 44(3): 537-543.
19. Ji W, Sun L, Lian K, et al. Rosiglitazone for obese patients fat cells in the influence of adiponectin expression. Chinese Heart J 2011; 23(5): 570-574.
20. Kubota N, Tecauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277(29): 25863-25866.
21. Sieminska L, Marek B, Kos-Kudla B, et al. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. J Endocrinol Invest 2004; 27(6): 528-534.
22. Chen Y G, Shen Z J, Hu JM, et al. Effect of adiponectin on endocrine and metabolism in patients with polycystic ovary syndrome. Jiang Su Yi Yao 2006; 32(2): 114-117.
23. Jiang J H, Xiao Y K, Li Q G, Zhang B. Relationship between adipokines and metabolic syndrome. Zhong Hua Nei Fen Mi Dai Xie Za Zhi 2010; 26(9): 762-764.
24. Wang S J, Jia W P, Bao Y Q, et al. Relationship between adipokines and obese. Zhong Hua Nei Fen Mi Dai Xie Za Zhi 2005; 21(1): 36-38.
25. Lele R D, Joshi S R, Gupte A. Association of adipocytokines (leptin, adiponectin TNF alpha) insulin and proinsulin with diabetes the Mumbai Obesity Project [MOP]. J Assoc Physicians India 2006; 54(9): 689-696.
26. Zhang H, Luo R, Tian F S. Effect of gender on overweight subcutaneous fat adiponectin mRNA expression. Zhong Guo Lao Nian Xue Za Zhi 2010; 30(9): 1169-1171.
27. Zhang H F, Zhao Z G. Measurement of overweight and obese children serum adiponectin and insulin. Zhong Hua Shi Yong Zhen Duan Yu Zhi Liao Za Zhi 2009; 23(3): 294-295.
28. Carmina E, Orio F, Palomba S, et al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005; 152(3): 389-394.
29. Ardawi M S, Rouzi A A. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005; 83(6): 1708-1716.
30. Panidis D, Kourtis A, Farmakiotis D, Mouslech T, Rousso D, Koliakos G. Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod 2003; 18(9): 1790-1796.
31. Osei K, Gaillard T, Schuster D. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type diabetes. Obes Res 2005; 13(1): 179-185.
32. Fan G L, Jing L H, Yi J P. Indexes changes of insulin resistance, blood fat and adiponectin in polycystic ovary syndrome patients with nonalcoholic fatty liver disease. Hebei Yi Yao 2011; 33(6): 856-857.
33. Holness M J, Munns M J, Sugden M C. Current concepts concerning the role of leptin in reproductive function. Mol Cell Endocrinol 1999; 157(1-2): 11-20.
34. Qian H B, Zhao J N. Leptin and bone formation. Yi Xue Yan Jiu Sheng Xue Bao 2006; 19(5): 462-464.
35. Shintani M, Ogawa Y, Nakao K. Insulin resistance, role of leptin and leptin receptor. Nihon Rinsho 2000; 58(2): 327-332.
36. Barash I A, Cheung C C, Weigle D S, et al. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996; 137(7): 3144-3147.
37. Lee G H, Proenca R, Montez J M, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379(6566): 632-635.
38. Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272(16): 10585-10593.
39. Reichart U, Renne U, Aigner B, Kratzsch J, Brockmann G A. A novel leptin receptor variant with a conservative amino acid substitution (1359V) in body weight selected and unselected mouse lines. Exp Clin Endocrinol Diabetes 2003; 111(5): 283-287.
40. Matsuoka N, Ogawa Y, Hosoda K, et al. Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutation or association f sequence variants with obesity. Diabetologia 1997; 40(10): 1204-1210.
41. Lu H Y, Xue Q, Xie D H, et al. The leptin receptor gene polymorphism and its influence of the blood lipid in patients with type 2 diabetes. Zhong Shan Da Xue Xue Bao (Yi Xue Ke Xue Ban) 2004; 25(3S): 93-95.
42. Chen Y. The relationship of Gln223Arg leptin receptor gene polymorphism and polycystic ovary syndrome insulin resistance and lipid metabolism. Lin Chuang Yi Yao Shi Jian 2011; 20(12): 912-914.